Beauty Manufacturing Solutions Corp.

CLOSEOUT LETTER Beauty Manufacturing Solutions Corp. MARCS-CMS 535116 — May 27, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. Whoojong (Peter) I. Song Recipient Title CEO Beauty Manufacturing Solutions Corp. 1250 Freeport Pkwy Coppell , TX 75019 United States psong@beautymanufacture.com Issuing Office: Dallas District Office United States Dear Mr. Song: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (CMS No. 535116) dated January 12, 2018 and our meeting with you on December 12, 2018. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ John W. Diehl, M.S. Commander, U.S. Public Health Service Director, Compliance Branch Office of Pharmaceutical Quality Operations, Division II Content current as of: 06/02/2021 Regulated Product(s) Drugs